OK "in relation to an illegitimate claim made against the US$4.2 million Letter of Credit supporting its exploration obligations in Block 7, Yemen"....Any ideas?
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%